Dementia: Causes, Treatments, and Outlook 2011PharmaLive Special Reports
August 1, 2011
68 Pages - SKU: ENPP6526282
Additional InformationThis special report focuses on the market leaders for dementia as well as the products in development anticipated to head this area in the years to come. This compilation’s prescription-product pipeline details the following information for each medicine: chemical or substance composition, intended indication, class of drug, clinical status, region of development, and the product developer/intended marketer. Pipeline status details preclinical development, Phase I, Phase I/II, Phase II, Phase II/III, Phase III, and awaiting approval. Regions of development include the United States, Europe, and Japan. A directory of dementia prescription-drug developers and marketers is included.
Additionally provided in this report is a listing of dementia medical-device entries, sorted by device class, as well as a directory of medical-device companies associated with the dementia field.
More CNS/Neurology reports by PharmaLive Special Reports
Top 15 Therapeutic Areas 2010 by PharmaLive Special Reports
Achieving approval for new therapies is becoming increasingly difficult. Within the past few months, the industry has experienced disappointments for several promising therapies in late-stage ...
CNS/Neurology Review and Outlook 2010 by PharmaLive Special ReportsSee all reports like this >>
CNS/neurology represents one of the two-largest therapeutic areas in the industry in terms products sales as well as the number of compounds in clinical development. ...
We can help you find what you need. Call us or write us:
Need help in your search?